The report "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bio absorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018", the North American peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a CAGR of 2.9% during 2013 to 2018.
Browse 108 market data tables and 24 figures spread through 245 pages and in-depth TOC on "North American Peripheral Vascular Devices Market"
Early buyers will receive 10% customization on this report.
This report studies the North American peripheral vascular devices market over the forecast period of 2013 to 2018.
The decreasing incidences of coronary angioplasties and the increasing peripheral intervention procedures have impacted the surgical equipment market significantly in North America.
The risk of restenosis in angioplasty procedures encourages the adoption of novel technologies to minimize post-surgical complications. Amongst various surgical devices, bio absorbable stents were found to be a major breakthrough in the market. The bio absorbable stents market is expected to witness a significant CAGR of 62.2% during the forecast period. The success achieved during the ongoing studies is also anticipated to spur the market adoption.
Get The PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=138691746
In addition to the next-generation stent, advanced diagnostic catheters such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) catheters are expected to grow at a faster pace in the coming years. Better diagnosis of vascular health as compared to conventional guiding catheters is the major reason behind the significant market growth.
In the market, retrievable inferior vena cava filter (IVC) occupies a notable market space as it becomes the gold standard for the treatment of DVT/PE in North America. Moreover, reduced risk of long-term post-surgical complication, which is common with permanent IVC filters, is expected to ensure a CAGR of 14.8% during the forecast period.
Analysis of the market dynamics identified the unique nature of the U.S. and Canadian markets. The technology adoption rate in Canada was found to be significantly high in 2013, though the total number of various cardiac procedures was much higher in the U.S. Bio absorbable stents are still under investigational study; however, it is available on a special access basis from Health Canada. Furthermore, angioplasty procedures through femoral route are still prevalent in the U.S. market; whereas, radial route angioplasty procedures gain significant adoption in the Canadian market. On the contrary, the U.S. market is significantly advanced in terms of required infrastructure as compared to the Canadian market. The Canadian market still lacks adequate number of cardiac facilities and skilled interventionists. Moreover, average waiting time for availing cardiac care is appalling in Canada; such factor is expected to fuel the adoption of advanced minimally invasive techniques in Canada in the coming years.
Inquire More For This Report:
Analysis of notable players has brought to light that the market is fairly consolidated with a few leading players. The notable players of this market include Abbott Laboratories (U.S.), Cordis Corporation (U.S.), Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), and Covidien, Inc. (U.S.).
Browse Related Reports:
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018.
Cardiovascular Information System Market by Applications (Catheterization Lab, Vascular Lab, Echocardiography, Electrocardiography, Electrophysiology), Delivery Mode, End Users (Small, Medium and Large Hospitals) & Components - Forecasts to 2018.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
1 South Dearborn Street,
21st Floor, Chicago,
Illinois, 60603, United States,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devicesConnect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets